Nicotine and caffeine-mediated modulation in the expression of toxicant responsive genes and vesicular monoamine transporter-2 in 1-methyl 4-phenyl-1,2,3,6-tetrahydropyridine-induced Parkinson's disease phenotype in mouse-Reference-Cited by-同舟云学术

Nicotine and caffeine-mediated modulation in the expression of toxicant responsive genes and vesicular monoamine transporter-2 in 1-methyl 4-phenyl-1,2,3,6-tetrahydropyridine-induced Parkinson's disease phenotype in mouse

Published:2008-05 Issue: Volume:1207 Page:193-206
ISSN:0006-8993
Container-title:Brain Research
language:en
Short-container-title:Brain Research

Author:

Singh Seema,Singh Kavita,Patel Suman,Patel Devendra Kumar,Singh Chetna,Nath Chandishwar,Singh Mahendra Pratap

Publisher

Elsevier BV

Subject

Developmental Biology,Clinical Neurology,Molecular Biology,General Neuroscience

Reference67 articles.

1. Parkinson's disease risk factors;Allam;Rev. Neurol.,2003

2. A chronic MPTP model reproducing the slow evolution of Parkinson's disease: evolution of motor symptoms in the monkey;Bezard;Brain Res.,1997

3. Preferential effects of nicotine and 4-(N-Methyl-N-nitrosamino)-1-(3-pyridyl)-1-butanone on mitochondrial glutathione-S-transferase A4-4 induction and increased oxidative stress in the rat brain;Bhagwat;Biochem. Pharmcol.,1998

4. A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding;Bradford;Anal. Biochem.,1976

5. A primate model of Parkinsonism: selective destruction of dopaminergic neurons in the pars compacta of the substantia nigra by N-methyl-4-phenyl-1,2,3,6-tetrahydropyridine;Burns;Proc. Natl. Acad. Sci. U. S. A.,1983

Cited by 37 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Small Particles, Big Potential: Polymeric Nanoparticles for Drug Delivery in Parkinson's Disease;Movement Disorders;2024-07-30

2. The impact of smoking status on clopidogrel responsiveness in patients with coronary artery disease who undergo percutaneous coronary intervention;F1000Research;2023-08-23

3. Therapeutic Potential of Heterocyclic Compounds Targeting Mitochondrial Calcium Homeostasis and Signaling in Alzheimer’s Disease and Parkinson’s Disease;Antioxidants;2023-06-15

4. Recent Advancements in Nanocarrier-assisted Brain Delivery of Phytochemicals Against Neurological Diseases;Neurochemical Research;2023-06-06

5. Enzymes in ready-to-drink tea and coffee products;Value-Addition in Beverages through Enzyme Technology;2023